company services research licensing investor contact careers

News home fact sheet investor news publications contact

News Welcome to the Proximagen Newsroom. In this section you will find information not only about Proximagen, but about the latest in neurodegenerative research. Check back often for updates. DATE: TITLE: MORE: SOURCE: 02/01/08 Share tips 2008 full story The Independent 23/06/07 Extras, extras! full story New Scientist 21/06/07 The Investment Column full story The Independent 14/06/07 Proximagen Shares Magazine Article full story Shares Magazine 07/03/07 Proximagen reveals promising alternative to L-DOPA for Parkinson's disease full story Scrip World Pharmaceutical News 23/11/06 Mini-Symposium and Pipeline Update full story Company release 24/07/06 Significant Contract Win full story Company release 22/05/06 In-Licencing Agreement full story Company release 24/11/05 Business initiative of the year award full story Company release 27/7/05 Proximagen interim results full story Financial Times 29/3/05 CNBC Power Lunch Interview (large file) media file CNBC 29/3/05 University floats spinout full story Daily Express 15/3/05 Proximagen to list on AiM full story Financial Times 3/12/04 Entrepreneurs Welcome Science Spotlight full story The Guardian 15/8/04 Neuroscience Research Company Launched full story The Messenger 18/3/04 Stock Market News: Proximagen is a spinout from Kings full story Market Release